---
title: "mogamulizumab - Peripheral T-cell lymphoma"
sidebar: mydoc_sidebar
permalink: mogamulizumabperipheraltcelllymphoma.html
toc: false 
---

{% include image.html file="mogamulizumabperipheraltcelllymphoma.png" alt="mogamulizumabperipheraltcelllymphoma" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C549035 | mogamulizumab | Drug |
| UniProt:P51679 | C-C chemokine receptor type 4 | Protein |
| GO:0038152 | C-C chemokine receptor CCR4 signaling pathway | BiologicalProcess |
| GO:0042098 | T cell proliferation | BiologicalProcess |
| MESH:D016411 | Peripheral T-cell lymphoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Mogamulizumab | NEGATIVELY REGULATES | C-C Chemokine Receptor Type 4 |
| C-C Chemokine Receptor Type 4 | POSITIVELY REGULATES | C-C Chemokine Receptor Ccr4 Signaling Pathway |
| C-C Chemokine Receptor Ccr4 Signaling Pathway | POSITIVELY REGULATES | T Cell Proliferation |
| T Cell Proliferation | POSITIVELY CORRELATED WITH | Peripheral T-Cell Lymphoma |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB12498#mechanism-of-action](https://go.drugbank.com/drugs/DB12498#mechanism-of-action){:target="_blank"}